Leading mRNA biotech companies' revenues 2022
Published by
In 2020, U.S.-based mRNA specialist Moderna generated worldwide revenues of around 803 million US dollars. Two years later, and thanks to its COVID-19 vaccine Spikevax, Moderna's revenue stood at more than 19 billion U.S. dollars.
The use of mRNA as a drug takes a fundamentally different approach to treating diseases than other drug classes. mRNA is the instruction that cells in the human body use to make proteins and send them to various locations in the body. mRNA drugs make use of normal biological processes to create proteins and achieve the desired therapeutic effect. This enables the potential treatment of a wide variety of diseases, many of which cannot be treated with current technologies.
The use of mRNA as a drug takes a fundamentally different approach to treating diseases than other drug classes. mRNA is the instruction that cells in the human body use to make proteins and send them to various locations in the body. mRNA drugs make use of normal biological processes to create proteins and achieve the desired therapeutic effect. This enables the potential treatment of a wide variety of diseases, many of which cannot be treated with current technologies.
